Rebecca Abergel to present at Sixth REAC/TS International Symposium
Nov 4, 2026
Rebecca Abergel, PhD, Co-Founder and Chief Scientific Officer of HOPO Therapeutics, will present an overview of the development of investigational HOPO-101 at the Sixth REAC/TS International Symposium: The Medical Basis for Radiation-Accident Preparedness, held November 3–5, 2026 at the Pollard Center in Oak Ridge, Tennessee. Commemorating the 50th anniversary of the Radiation Emergency Assistance Center/Training Site (REAC/TS), the symposium brings together experts from across the United States and around the world to discuss emerging nuclear risks and innovations in the management of radiation injuries and illnesses.
